Patents and Intellectual Property in Biomedical Science: A History in Two Tales
How the US licensing of NIH and other government funded drug and biomedical research became a grift for Big Pharma.
Read more...How the US licensing of NIH and other government funded drug and biomedical research became a grift for Big Pharma.
Read more...Continuing the debate on whether democracy is viable in a capitalist regime.
Read more...A detailed discussion of Russia’s effort to foster an ideological counterpoint to US hegemony, particularly via Putin speeches.
Read more...~ Today’s Water Cooler ~
Read more...Yes, Virginia, ultra-processed food is a health hazard. But what to do?
Read more...Even by the normal standards of investor-state dispute settlements (ISDS), Pfizer and BioNtech’s lawsuit against the government of Poland for refusing to take delivery of more unwanted vaccines is especially egregious.
Read more...e body politic in the West is not at all healthy. Why is there so much denial about that?
Read more...Walker Todd and Bill Bergman expose the untold story of banking instability, regulatory battles, and the struggle to protect the public.
Read more...What it says on the tin.
Read more...~ Today’s Water Cooler: Open Thread ~
Read more...Things are going from bad to worse for Ukraine, and at an accelerating pace too.
Read more...Though firms passed rising upstream costs on to retailers at similar absolute rates, the increases for low-end products are disproportionately large when measured in percentages – a pattern with real consequences for consumers.
Read more...Yves here. While there is a lot of merit in the latest discussion between Radhika Desai and Micheal Hudson on their favorite topic of mutlipolarity, I feel compelled to correct some imprecisions. The video depicts the “German government” as having “raised” the debt brake but then “not being allowed” with no depiction of agency, to […]
Read more...